Email Contact Phone Company Visit Website

Global HQ Head Office

601 Riverside Avenue


U.S.:+1 877.776.3706; EMEA:+44 20 8081 3840; APAC:+63 2 8802 6299


Get Info
[email protected]
Back to all FIS announcements

SunGard Identifies Ten Trends in OTC Derivatives for 2012

Peter Banham, head of strategy for SunGard’s capital markets business, said, “Regulatory changes are transforming the OTC derivatives space, from execution to settlement. Market participants need to manage large volumes of data in order to clear and process trades. New pressures on the cost and the more effective use of capital make it more important to have automated and real-time capital controls. SunGard is helping firms capitalize on these changes for all OTC and listed instruments by providing a suite of established, front-to-back solutions that can manage both centrally cleared and bilateral trades.”

The ten trends and their impact on the OTC derivatives landscape as identified by SunGard are:

1. Regulations such as Basel III, Dodd-Frank, EMIR and MiFID II are spurring financial services firms to improve their return on capital rather than simply focus on top line revenues.
2. Shrinking profit margins may drive existing players to exit certain asset classes, such as structured equity, rates or credit markets.
3. Competition will increase as greater transparency into OTC derivatives pricing and lower barriers to entry attract new players to the market.
4. Firms will leverage new electronic trading capabilities for OTC derivatives to help reduce running costs and improve returns, particularly in their flow trading and market-making businesses.
5. The cost of participating in OTC derivatives trading will rise, with the introduction of central counterparties altering the risk profile and margin requirements of OTC derivatives portfolios.
6. Clearing houses and market participants will require a consolidated view of collateral assets and margin movements to manage new pressures on margin and liquidity as well as new regulatory requirements for collateral.
7. The need to optimize collateral and leverage every margin offset opportunity will become more pressing as the new capital charges take hold.
8. Real-time risk analytics will become a necessity, with market best practice moving towards the incorporation of Credit Value Adjustment on a pre-deal basis.
9. Firms will need to aggregate data from across asset classes and business silos as regulatory agencies shift the burden of reporting position limits and large trades from exchanges or clearing houses to firms.
10. Firms will demand agility and adaptability from their technology given the uncertainty about the exact details and timelines for the new rules.

Kevin McPartland, principal and director of fixed income research at TABB Group, said, “Though clearing is getting faster, it is also about to get much more complicated. Regulatory mandates and good old-fashioned competition will force more complex products into the clearing environment. Furthermore, portfolios that once contained only OTC derivatives products will now contain a mix of both cleared and non-cleared trades. This creates risk management issues as calculating margin becomes even more complicated. As a result, technology will become a significant part of each market participant’s competitive advantage.”